Company: REVB
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0000950170-25-083815
Chunk: 6

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 6
---
 has been forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As the beneficial owner, you have the right to instruct this organization on how to vote your shares. See “How Will my Shares be Voted if I Give No Specific Instruction?” below for information on how shares held in street name will be voted without instructions provided.

Who may attend the Annual Meeting?

Only record holders and beneficial owners of our common stock, or their duly authorized proxies, may attend the Annual Meeting. If your shares of common stock are held in street name, you will need to provide a copy of a brokerage statement or other documentation reflecting your stock ownership as of the Record Date.

What am I voting on?

There are eight matters scheduled for a vote:

To elect one (1) Class C director of the Company to serve until the 2028 Annual Meeting of Stockholders or until their successors have been duly elected and qualified;

To approve an amendment to the 2021 Equity Incentive Plan to adjust the number of shares reserved under the Plan under its “evergreen” feature quarterly rather than annually;

To approve, on an advisory basis, the compensation of the Company’s named executive officers and directors;

To approve, on an advisory basis, the frequency of three years for future advisory votes on executive compensation;

To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation one or more times to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-two to a maximum of a one-for-250 split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock splits, if at all, within one year of the date the proposal is approved by stockholders;

To approve the reservation and issuance of shares of our common stock pursuant to Class H Common Stock Warrants (the “Warrants”), dated May 29. 2025, entered into and between us and certain purchasers in connection with a Stock Purchase Agreement dated the same date, to the extent that the issuances under the Warrants might exceed 20% of the Company’s total outstanding shares, which could trigger the share issuance cap under Rule 5635(d) of the Nasdaq Stock Market Rules (the “Exchange Cap”);

To approve the change of domicile of the Company from the State of Delaware to